Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02

Stopped The Relamorelin program is being terminated solely based on a business decision

Conditions

• Gastroparesis
• Diabetes Mellitus

Interventions

• DRUG: Placebo
• DRUG: Relamorelin

Sponsor

Allergan